Skip to main content
SpringerLink
Log in

Dermpath and Clinic: How to manage adverse reactions to biological agents

  • Residents’ Corner
  • Published:
European Journal of Dermatology

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Perino E, Freymond N, Devouassoux G, Nicolas J-F, Berard F. Xolair-induced recurrent anaphylaxis through sensitization to the excipient polysorbate. Ann Allergy Asthma Immunol 2018; 120(6): 664–6.

    Article  Google Scholar 

  2. Isabwe GAC, Garcia Neuer M, de Las Vecillas Sanchez L, Lynch D-M, Marquis K, Castells M. Hypersensitivity reactions to therapeutic monoclonal antibodies: Phenotypes and endotypes. J Allergy Clin Immunol 2018; 142(1): 159–170.e2.

    Article  CAS  Google Scholar 

  3. Pichler WJ. Adverse side-effects to biological agents. Allergy 2006; 61(8): 912–20.

    Article  CAS  Google Scholar 

  4. Galvão VR, Castells MC. Hypersensitivity to biological agents-updated diagnosis, management, and treatment. J Allergy Clin Immunol Pract 2015; 3(2): 175–85.

    Article  Google Scholar 

  5. Lieberman P. The unusual suspects: a surprise regarding reactions to omalizumab. Allergy Asthma Proc 2007; 28(3): 259–61.

    Article  CAS  Google Scholar 

  6. Castells M. Desensitization for drug allergy. Curr Opin Allergy Clin Immunol 2006; 6(6): 476–81.

    Article  CAS  Google Scholar 

  7. Castells M. Rapid desensitization for hypersensitivity reactions to medications. Immunol Allergy Clin North Am 2009; 29(3): 585–606.

    Article  Google Scholar 

  8. Hsu Blatman KS, Castells MC. Desensitizations for chemotherapy and monoclonal antibodies: indications and outcomes. Curr Allergy Asthma Rep 2014; 14(8): 453.

    Article  Google Scholar 

  9. del Carmen Sancho M, Breslow R, Sloane D, Castells M. Desensitization for hypersensitivity reactions to medications. Chem Immunol Allergy 2012; 97: 217–33.

    Article  CAS  Google Scholar 

  10. Brennan PJ, Rodriguez Bouza T, Hsu FI, Sloane DE, Castells MC. Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment. J Allergy Clin Immunol 2009; 124(6): 1259–66.

    Article  CAS  Google Scholar 

  11. Picard M, Galvão VR. Current knowledge and management of hypersensitivity reactions to monoclonal antibodies. J Allergy Clin Immunol Pract 2017; 5(3): 600–9.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. CIRI, Centre International de Recherche en Infectiologie, (Team Immunology of Skin Allergy and Vaccination); INSERM, U1111; Univ Lyon; Université de Lyon 1; Ecole Normale Supérieure de Lyon, CNRS, UMR 5308, Lyon, France

    Marine-Alexia Lefevre & Audrey Nosbaum

  2. Department of Dermatology and Allergology, Centre Hospitalier Universitaire de Saint-Etienne, Saint-Priest-en-Jarez, France

    Marine-Alexia Lefevre & Audrey Nosbaum

  3. Department of Allergy and Clinical Immunology, Centre Hospitalier Lyon-Sud, Pierre-Benite, France

    Audrey Nosbaum

Authors
  1. Marine-Alexia Lefevre
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Audrey Nosbaum
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marine-Alexia Lefevre.

Additional information

Disclosures

Funding source: none. Conflicts of interest: none.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lefevre, MA., Nosbaum, A. Dermpath and Clinic: How to manage adverse reactions to biological agents. Eur J Dermatol 31, 426–427 (2021). https://doi.org/10.1684/ejd.2021.4070

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1684/ejd.2021.4070

Search

Navigation